Elkton, Va.
Merck is engaged in a $57-million expansion of its Stonewall plant in Elkton, Va. to accommodate demand for its Gardasil vaccine. The project is the second phase of expansion at the facility and includes construction of a new building and installation of purification technologies for pharmaceutical production. The first $40-million phase included a vaccine fermentation unit and was completed in 2006.
